Citation Impact
Citing Papers
Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
2019
An update on the regulatory mechanisms of NLRP3 inflammasome activation
2021
NLRP3 lacking the leucine-rich repeat domain can be fully activated via the canonical inflammasome pathway
2018
The role of inflammasomes in kidney disease
2019
Innate immunity in diabetic kidney disease
2020
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
2019 Standout
Targeting the NLRP3 inflammasome in inflammatory diseases
2018
Pyroptosis: mechanisms and diseases
2021 Standout
Development of covalent NLRP3 inflammasome inhibitors: Chemistry and biological activity
2018
Diverging inflammasome signals in tumorigenesis and potential targeting
2019
MCC950 closes the active conformation of NLRP3 to an inactive state
2019
NLRP3: A promising therapeutic target for autoimmune diseases
2018
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Role of pyroptosis in cardiovascular diseases
2018
Tranilast directly targets NLRP 3 to treat inflammasome‐driven diseases
2018
The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
2019 Standout
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
Chloride regulates dynamic NLRP3-dependent ASC oligomerization and inflammasome priming
2018
The NLRP3 Inflammasome as a Pharmacological Target
2019
Works of Aoli Wang being referenced
Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity
2018
Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders
2017